Related Experiment Videos
Azapirones: an alternative to benzodiazepines for anxiety
1Department of Psychiatry, Pennsylvania State University College of Medicine, Milton S. Hershey Medical Center, Hershey, USA.
American Family Physician
|May 15, 1996
Summary
Azapirones, like buspirone, offer effective anxiety and depression treatment with a good safety profile. This psychotherapeutic drug class shows promise for various serotonin-related disorders.
Area of Science:
- Pharmacology
- Psychiatry
Background:
- Azapirones represent a novel class of psychotherapeutic agents.
- These drugs possess both anxiolytic and antidepressant properties.
- They offer an improved benefit-to-risk ratio compared to older treatments.
Purpose of the Study:
- To introduce azapirones as a significant advancement in psychotherapeutic drug development.
- To highlight the characteristics and clinical utility of buspirone, the primary azapirone in use.
- To discuss the suitability of buspirone for specific patient populations and conditions.
Main Methods:
- Review of existing clinical data and pharmacological profiles of azapirones.
- Analysis of buspirone's mechanism of action as a partial serotonin agonist.
- Evaluation of clinical indications and patient tolerability, particularly in the elderly.
Main Results:
- Buspirone exhibits low abuse potential and lacks sedative or cognitive impairing effects.
- No significant withdrawal symptoms are associated with buspirone use.
- Buspirone is well-tolerated, especially by elderly patients.
- Demonstrated efficacy in chronic anxiety and mixed anxiety/depression states.
Conclusions:
- Azapirones, exemplified by buspirone, mark a significant therapeutic advance.
- Buspirone is a well-tolerated option for chronic anxiety and related disorders.
- Further efficacy is noted across various serotonin-related conditions.